We use self-assembled hyaluronic acid nanomedicine and

peripheral CB1R antagonist for treating chronic inflammatory diseases.

​

Also, we find out pathophysiological mechanisms and specific control methods

to development of therapeutic intervention for inflammatory disease.

​​